Nikhil Wagle

Biography
Nikhil Wagle, MD, is Senior Vice President and Global Head of Translational Medicine at Genentech, a member of the Roche Group. In this role, Nikhil is responsible for leading a global team for the innovation, development and execution of biomarker and diagnostic strategies to drive preclinical and clinical development across a rich pipeline of investigational therapeutics, and conduct foundational disease-oriented translational research across all therapeutic areas to help catalyze the development of new medicines and discover new therapeutic strategies. Prior to joining Genentech in 2023, Nikhil was an Associate Professor of Medicine at Harvard Medical School, a medical oncologist at Dana-Farber Cancer Institute, and an Institute Member of the Broad Institute of MIT and Harvard. Nikhil helped pioneer the development and use of next-generation sequencing for precision oncology, and made major contributions to the understanding of mechanisms of resistance to targeted therapies in breast cancer and cancer types.